GREMUBAMAB
UNII 3QG7W0YN2Z

Substance Identification & Data

This profile provides standardized clinical and technical data for Gremubamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 3QG7W0YN2Z.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1800381-36-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

3QG7W0YN2Z

CAS Registry Number

1800381-36-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

GREMUBAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C166690

National Cancer Institute reference terminology for clinical and research data.

INN ID

10909

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

EF-80

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Gremubamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

GREMUBAMAB

Common Names & Synonyms

GREMUBAMAB [INN]

GREMUBAMAB [USAN]

GREMUBAMAB [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(PSEUDOMONAS AERUGINOSA SURFACE EXOPOLYSACCHARIDE PSL/TYPE III SECRETION PROTEIN PCRV) (HUMAN MONOCLONAL MEDI3902 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MEDI3902 .KAPPA.-CHAIN, DIMER

SYS